Esther12
Senior Member
- Messages
- 13,774
But that is an issue about the difference between doctors' objectives and patients' objectives rather than the statistical issue we were debating. In the end I doubt it will turn out to have been a best endpoint because it will become accepted fairly soon that the trial is uninterpretable - particularly if the authors continue to produce further data that shoots their own hypotheses in the foot.
Maybe I did miss something, but don't those statistical matters depend upon assumptions about researchers having using valuable endpoints? If we're still not confident in our ability to do that for some CFS trials, then wouldn't that favour the sort of analysis User9876 suggested?